INTEGRATE-HTA

Integrated health technology assessment for the evaluation

of complex technologies

For project outputs (e.g. abstracts, presentations, newsletters) and more

information please visit our website:

www.integrate-hta.eu

or contact us at

info@integrate-hta.eu

INTEGRATE-HTA INTEGRATE-HTA

Coordinator

CONSORTIUM

Partners

Ecorys Rotterdam, the Netherlands Contact: Wija Oortwijn

Ludwig Maximilians University Munich, Germany Contact: Eva Rehfuess

Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands Contact: Gert Jan van der Wilt

Università Cattolica del Sacro Cuore, Rome, Italy Contact: Dario Sacchini

University of Oslo, Norway Contact: Bjørn Hofmann and Kristin Bakke Lysdahl

University of Sheffield, United Kingdom Contact: Louise Brereton

University of Bremen, Germany Contact: Ansgar Gerhardus & Kati Mozygemba

This project is co-funded by the European Union

The number of people that suffer from one or more chronic diseases is rapidly increasing around the globe. To adequately address this issue, complex health technologies, such as disease management programs or specialized palliative care services, are needed. Health technology assessment (HTA) is defined as “the systematic evaluation of properties, effects, and/or impacts of health technology. It may address the direct, intended consequences of technologies as well as indirect, unintended consequences. Its main purpose is to inform decision making in policy and practice.” Despite considerable achievements in recent years, contemporary HTA is not adequately equipped to assess complex technologies. The INTEGRATE-HTA project aims to develop concepts and methods for a comprehensive, patient–centred, integrated (as opposed to simultaneous, but independent) assessment of complex technologies that enable the assessment of: effectiveness and economic, socio-

cultural, ethical, and legal issues,

patient preferences and patient-specific moderators of treatment,

context, setting, and implementation.

AIM

INTEGRATE-HTA INTEGRATE-HTA

INTEGRATE-HTA will provide methodological guidance for the assessment of complex health technologies. We currently: - have established stakeholder advisory panels (e.g. patients, carers, and health professionals) in all partner countries and in Poland and Lithuania; - have developed logic model templates to provide a concise graphical overview of the complex concepts of palliative care (case); - test draft guidances for assessing the effectiveness, socio-cultural, ethical, economic, and legal issues, patient preferences, the context and implementation of the technology, as well as integration of these issues.

<DISCLAIMER: The sole responsibility for the content of this flyer lies with the authors. It

does not necessarily reflect the opinion of the European Union. The European Commission

is not responsible for any use that may be made of the information contained therein.>

WORKFLOW INTERIM RESULTS

TIMELINE AND FUNDING The project runs from January 2013 until December 2015. The project is co-funded by the European Union under the Seventh Framework Programme (FP7-Health-2012-Innovation); grant agreement number 306141.

The findings of the project will inform HTA networks, national and regional HTA agencies, researchers, World Health Organization, the Cochrane Collaboration, the Campbell Collaboration, international and national health policy-makers, healthcare professionals, patients, insurers, industry, and the public.

TARGET AUDIENCES

Innovative concepts and methods of integrating all relevant issues and modifying factors will be developed and tested using a case study on palliative care. Feedback from the case study is subsequently used to adapt methods and concepts for broader application in the assessment of other complex technologies.